TY - JOUR
T1 - Evaluation and medical management of erectile dysfunction
AU - Beckman, Thomas J.
AU - Abu-Lebdeh, Haitham S.
AU - Mynderse, Lance A.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2006/3
Y1 - 2006/3
N2 - Most men older than 60 years experience some degree of erectile dysfunction (ED). The physiology of erections is complex, with contributions from hormonal, vascular, psychological, neurologic, and cellular components. ED is strongly associated with cardiovascular risk factors, and this fact plays a major role in the prevention and treatment of ED. In this article, we review the evaluation of ED in terms of history, physical examination, and common laboratory studies. Additionally, we review major considerations when prescribing phosphodiesterase type 5 inhibitors and other medical treatments, including intraurethral alprostadil, penile injection therapy, and testosterone replacement.
AB - Most men older than 60 years experience some degree of erectile dysfunction (ED). The physiology of erections is complex, with contributions from hormonal, vascular, psychological, neurologic, and cellular components. ED is strongly associated with cardiovascular risk factors, and this fact plays a major role in the prevention and treatment of ED. In this article, we review the evaluation of ED in terms of history, physical examination, and common laboratory studies. Additionally, we review major considerations when prescribing phosphodiesterase type 5 inhibitors and other medical treatments, including intraurethral alprostadil, penile injection therapy, and testosterone replacement.
UR - http://www.scopus.com/inward/record.url?scp=33644694941&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644694941&partnerID=8YFLogxK
U2 - 10.4065/81.3.385
DO - 10.4065/81.3.385
M3 - Review article
C2 - 16529142
AN - SCOPUS:33644694941
SN - 0025-6196
VL - 81
SP - 385
EP - 390
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 3
ER -